AVIEW LCS vs eMurmur Heart AI
AI Verdict
Choose AVIEW LCS if…
Choose AVIEW LCS if your primary need is comprehensive, AI-powered analysis of low-dose CT scans for lung cancer screening, COPD assessment, and coronary artery calcification. This tool is ideal for radiology departments seeking to automate nodule detection, quantify emphysema, and generate detailed reports from imaging data to enhance diagnostic accuracy and streamline workflows. It excels in providing in-depth insights from cross-sectional imaging.
View AVIEW LCS →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if your focus is on AI-assisted auscultation for the detection and analysis of heart and lung sounds, particularly for screening and monitoring murmurs. This platform is well-suited for clinicians in primary care, cardiology, or telehealth who require a mobile-friendly, hardware-neutral solution to record, analyze, and compare auscultation data, facilitating early detection and remote patient assessment.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Pricing | Subscription or one-off payment | Contact for quote |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Web-based, Mobile App, API integration |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers broad accessibility through mobile apps, web portals, and hardware-neutral compatibility, supporting flexible use cases including remote auscultation for telehealth. AVIEW LCS, while streamlining radiology workflows with PACS/RIS integration and automated reports, is more specialized for CT interpretation within a radiology department.
Clinical Value
AVIEW LCSAVIEW LCS provides comprehensive, quantitative analysis for multiple critical conditionsu2014lung cancer, COPD, and coronary artery calcificationu2014from a single low-dose CT scan, significantly impacting early detection and risk stratification. Clinical studies have shown its effectiveness in reducing radiologist workload and improving nodule detection accuracy. eMurmur Heart AI also offers significant value by objectifying auscultation for heart and lung sounds, with high sensitivity and specificity for murmur detection.
Pricing & Value
TieBoth AVIEW LCS and eMurmur Heart AI require direct contact for pricing information, making it impossible to conduct a head-to-head comparison on this dimension. Both tools offer substantial clinical benefits that could lead to significant value and cost savings within their respective applications.
Enterprise Readiness
AVIEW LCSAVIEW LCS offers more extensive deployment options, including cloud, hybrid, local dedicated hardware, and virtualized solutions, which are crucial for large enterprises with diverse IT infrastructures and data governance needs. Its explicit integration with PACS/RIS further enhances its readiness for complex hospital imaging systems. Both tools are FDA-cleared, HIPAA compliant, and offer BAAs.
Innovation
eMurmur Heart AIeMurmur Heart AI's innovation lies in transforming the subjective practice of auscultation into an objective, AI-powered, and hardware-agnostic diagnostic tool, enabling new care models like remote and telehealth applications. AVIEW LCS innovates by performing multi-disease screening from a single CT scan and automating follow-up comparisons, optimizing existing imaging workflows.
Support & Docs
TieNeither the provided structured facts nor the web search results offer specific details regarding the availability, quality, or scope of support services or documentation for either AVIEW LCS or eMurmur Heart AI. Therefore, it is not possible to differentiate between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Primary Application | AI-powered solution for the detection and analysis of lung nodules, lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. | AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. |
| Company | Coreline Soft Co. | CSD Labs |
| Lung-Related AI Features | Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation, Emphysema quantification (LAA index), Automated comparison of nodules in follow-up CT scans. | Automated lung sound analysis (crackles, wheezes). |
| Heart-Related AI Features | Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass). | Automated heart sound analysis (S1, S2, murmurs), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights (loudness ratios of S1, systole, S2, diastole). |
| Integration/Compatibility | Integration with PACS/RIS and third-party platforms. | Supports digital stethoscopes, hardware-neutral and stethoscope agnostic platform compatibility, Mobile app (iOS, Android) and web portal for access. |
| Reporting/Output | Comprehensive, automated report generation. | Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring. |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and eMurmur Heart AI.